Cargando…

Determination of optimal deployment strategy for REBOA in patients with non-compressible hemorrhage below the diaphragm

BACKGROUND: Non-compressible truncal hemorrhage (NCTH) is the leading cause of preventable death after trauma. Resuscitative endovascular balloon occlusion of the aorta (REBOA) achieves temporary hemorrhage control, supporting cardiac and cerebral perfusion prior to definitive hemostasis. Aortic zon...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnson, Nicholas L, Wade, Charles E, Fox, Erin E, Meyer, David E, Fox, Charles J, Moore, Ernest E, Morrison, Jonathan, Scalea, Thomas, Bulger, Eileen M, Inaba, Kenji, Morse, Bryan C, Moore, Laura J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907878/
https://www.ncbi.nlm.nih.gov/pubmed/33693060
http://dx.doi.org/10.1136/tsaco-2020-000660
_version_ 1783655586230960128
author Johnson, Nicholas L
Wade, Charles E
Fox, Erin E
Meyer, David E
Fox, Charles J
Moore, Ernest E
Morrison, Jonathan
Scalea, Thomas
Bulger, Eileen M
Inaba, Kenji
Morse, Bryan C
Moore, Laura J
author_facet Johnson, Nicholas L
Wade, Charles E
Fox, Erin E
Meyer, David E
Fox, Charles J
Moore, Ernest E
Morrison, Jonathan
Scalea, Thomas
Bulger, Eileen M
Inaba, Kenji
Morse, Bryan C
Moore, Laura J
author_sort Johnson, Nicholas L
collection PubMed
description BACKGROUND: Non-compressible truncal hemorrhage (NCTH) is the leading cause of preventable death after trauma. Resuscitative endovascular balloon occlusion of the aorta (REBOA) achieves temporary hemorrhage control, supporting cardiac and cerebral perfusion prior to definitive hemostasis. Aortic zone selection algorithms vary among institutions. We evaluated the efficacy of an algorithm for REBOA use. METHODS: A multicenter prospective, observational study conducted at six level 1 trauma centers over 12 months. Inclusion criteria were age >15 years with evidence of infradiaphragmatic NCTH needing emergent hemorrhage control within 60 min of ED arrival. An algorithm characterized by the results of focused assessment with sonography in trauma and pelvic X-ray was assessed post hoc for efficacy in a cohort of patients receiving REBOA. RESULTS: Of the 8166 patients screened, 78 patients had a REBOA placed. 21 patients were excluded, leaving 57 patients for analysis. The algorithm ensures REBOA deployment proximal to hemorrhage source to control bleeding in 98.2% of cases and accurately predicts the optimal REBOA zone in 78.9% of cases. If the algorithm was violated, bleeding was optimally controlled in only 43.8% (p=0.01). Three (75.0%) of the patients that received an inappropriate zone 1 REBOA died, two from multiple organ failure (MOF). All three patients that died with an inappropriate zone 3 REBOA died from exsanguination. DISCUSSION: This algorithm ensures proximal hemorrhage control and accurately predicts the primary source of hemorrhage. We propose a new algorithm that will be more inclusive. A zone 3 REBOA should not be performed when a zone 1 is indicated by the algorithm as 100% of these patients exsanguinated. MOF, perhaps from visceral ischemia in patients with an inappropriate zone 1 REBOA, may have been prevented with zone 3 placement or limited zone 1 occlusion time. LEVEL OF EVIDENCE: Level III.
format Online
Article
Text
id pubmed-7907878
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-79078782021-03-09 Determination of optimal deployment strategy for REBOA in patients with non-compressible hemorrhage below the diaphragm Johnson, Nicholas L Wade, Charles E Fox, Erin E Meyer, David E Fox, Charles J Moore, Ernest E Morrison, Jonathan Scalea, Thomas Bulger, Eileen M Inaba, Kenji Morse, Bryan C Moore, Laura J Trauma Surg Acute Care Open Guidelines/Algorithms BACKGROUND: Non-compressible truncal hemorrhage (NCTH) is the leading cause of preventable death after trauma. Resuscitative endovascular balloon occlusion of the aorta (REBOA) achieves temporary hemorrhage control, supporting cardiac and cerebral perfusion prior to definitive hemostasis. Aortic zone selection algorithms vary among institutions. We evaluated the efficacy of an algorithm for REBOA use. METHODS: A multicenter prospective, observational study conducted at six level 1 trauma centers over 12 months. Inclusion criteria were age >15 years with evidence of infradiaphragmatic NCTH needing emergent hemorrhage control within 60 min of ED arrival. An algorithm characterized by the results of focused assessment with sonography in trauma and pelvic X-ray was assessed post hoc for efficacy in a cohort of patients receiving REBOA. RESULTS: Of the 8166 patients screened, 78 patients had a REBOA placed. 21 patients were excluded, leaving 57 patients for analysis. The algorithm ensures REBOA deployment proximal to hemorrhage source to control bleeding in 98.2% of cases and accurately predicts the optimal REBOA zone in 78.9% of cases. If the algorithm was violated, bleeding was optimally controlled in only 43.8% (p=0.01). Three (75.0%) of the patients that received an inappropriate zone 1 REBOA died, two from multiple organ failure (MOF). All three patients that died with an inappropriate zone 3 REBOA died from exsanguination. DISCUSSION: This algorithm ensures proximal hemorrhage control and accurately predicts the primary source of hemorrhage. We propose a new algorithm that will be more inclusive. A zone 3 REBOA should not be performed when a zone 1 is indicated by the algorithm as 100% of these patients exsanguinated. MOF, perhaps from visceral ischemia in patients with an inappropriate zone 1 REBOA, may have been prevented with zone 3 placement or limited zone 1 occlusion time. LEVEL OF EVIDENCE: Level III. BMJ Publishing Group 2021-02-23 /pmc/articles/PMC7907878/ /pubmed/33693060 http://dx.doi.org/10.1136/tsaco-2020-000660 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Guidelines/Algorithms
Johnson, Nicholas L
Wade, Charles E
Fox, Erin E
Meyer, David E
Fox, Charles J
Moore, Ernest E
Morrison, Jonathan
Scalea, Thomas
Bulger, Eileen M
Inaba, Kenji
Morse, Bryan C
Moore, Laura J
Determination of optimal deployment strategy for REBOA in patients with non-compressible hemorrhage below the diaphragm
title Determination of optimal deployment strategy for REBOA in patients with non-compressible hemorrhage below the diaphragm
title_full Determination of optimal deployment strategy for REBOA in patients with non-compressible hemorrhage below the diaphragm
title_fullStr Determination of optimal deployment strategy for REBOA in patients with non-compressible hemorrhage below the diaphragm
title_full_unstemmed Determination of optimal deployment strategy for REBOA in patients with non-compressible hemorrhage below the diaphragm
title_short Determination of optimal deployment strategy for REBOA in patients with non-compressible hemorrhage below the diaphragm
title_sort determination of optimal deployment strategy for reboa in patients with non-compressible hemorrhage below the diaphragm
topic Guidelines/Algorithms
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907878/
https://www.ncbi.nlm.nih.gov/pubmed/33693060
http://dx.doi.org/10.1136/tsaco-2020-000660
work_keys_str_mv AT johnsonnicholasl determinationofoptimaldeploymentstrategyforreboainpatientswithnoncompressiblehemorrhagebelowthediaphragm
AT wadecharlese determinationofoptimaldeploymentstrategyforreboainpatientswithnoncompressiblehemorrhagebelowthediaphragm
AT foxerine determinationofoptimaldeploymentstrategyforreboainpatientswithnoncompressiblehemorrhagebelowthediaphragm
AT meyerdavide determinationofoptimaldeploymentstrategyforreboainpatientswithnoncompressiblehemorrhagebelowthediaphragm
AT foxcharlesj determinationofoptimaldeploymentstrategyforreboainpatientswithnoncompressiblehemorrhagebelowthediaphragm
AT mooreerneste determinationofoptimaldeploymentstrategyforreboainpatientswithnoncompressiblehemorrhagebelowthediaphragm
AT morrisonjonathan determinationofoptimaldeploymentstrategyforreboainpatientswithnoncompressiblehemorrhagebelowthediaphragm
AT scaleathomas determinationofoptimaldeploymentstrategyforreboainpatientswithnoncompressiblehemorrhagebelowthediaphragm
AT bulgereileenm determinationofoptimaldeploymentstrategyforreboainpatientswithnoncompressiblehemorrhagebelowthediaphragm
AT inabakenji determinationofoptimaldeploymentstrategyforreboainpatientswithnoncompressiblehemorrhagebelowthediaphragm
AT morsebryanc determinationofoptimaldeploymentstrategyforreboainpatientswithnoncompressiblehemorrhagebelowthediaphragm
AT moorelauraj determinationofoptimaldeploymentstrategyforreboainpatientswithnoncompressiblehemorrhagebelowthediaphragm
AT determinationofoptimaldeploymentstrategyforreboainpatientswithnoncompressiblehemorrhagebelowthediaphragm